So I really depend on my medication." Sir Peter Luff, a former defence minister and MP for Mid Worcestershire, explained how ...

Wrexham manager Phil Parkinson described his team's performance as "nowhere near good enough" following their 3-2 defeat to ...

A few years after Patrick Morrissey, 53, learned he had early onset Parkinson's disease, a group of friends came to him with ...

The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...

The Eagles are shaking up their live show. The shift comes as guitarist Steuart Smith announced a struggle with Parkinson’s ...

A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox Foundation, found that an overwhelming 84% of patients with Parkinson's ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...

At Rock Steady Boxing West Michigan, patients are using boxing as a form of therapy to combat the effects of Parkinson's.

Sleep problems are very common in people with Parkinson’s disease and are associated with poorer quality of life in patients, ...

Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...